Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Fagan

Showing results (351-360 of 489) with videos related to

Pageof 49
Sort By:
Alzheimer'S Research & Therapy|September 27, 2018
Non-beta-amyloid/tau cerebrospinal fluid markers inform staging and progression in Alzheimer's diseaseUmesh Gangishetti, J Christina Howell, Richard J Perrin, et al.
Annals of Neurology|December 24, 2005
Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humansAnne M Fagan, Mark A Mintun, Robert H Mach, et al.
American Journal of Hospital Pharmacy|December 1, 1976
Computerized consultation system for selection of antimicrobial therapyS M Wraith, J S Aikins, B G Buchanan, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 26, 2018
The impact of preanalytical variables on measuring cerebrospinal fluid biomarkers for Alzheimer's disease diagnosis: A reviewOskar Hansson, Alvydas Mikulskis, Anne M Fagan, et al.
IBRO Neuroscience Reports|April 12, 2021
Intracisternal administration of tanshinone IIA-loaded nanoparticles leads to reduced tissue injury and functional deficits in a porcine model of ischemic strokeElizabeth S Waters, Erin E Kaiser, Xueyuan Yang, et al.
Sleep|March 18, 2022
Adverse driving behaviors are associated with sleep apnea severity and age in cognitively normal older adults at risk for Alzheimer's diseaseJason M Doherty, Catherine M Roe, Samantha A Murphy, et al.
Neuroimage. Clinical|March 23, 2019
Quantification of white matter cellularity and damage in preclinical and early symptomatic Alzheimer's diseaseQing Wang, Yong Wang, Jingxia Liu, et al.
Frontiers in Neurology|February 8, 2021
Magnetic Resonance Imaging and Gait Analysis Indicate Similar Outcomes Between Yucatan and Landrace Porcine Ischemic Stroke ModelsSydney E Sneed, Kelly M Scheulin, Erin E Kaiser, et al.
Brain and Behavior|February 28, 2018
Neurodegenerative disease biomarkers Aβ<sub>1-40</sub>, Aβ<sub>1-42</sub>, tau, and p-tau<sub>181</sub> in the vervet monkey cerebrospinal fluid: Relation to normal aging, genetic influences, and cerebral amyloid angiopathyJason A Chen, Scott C Fears, Anna J Jasinska, et al.
Clinical Chemistry|March 11, 2018
Neurogranin as Cerebrospinal Fluid Biomarker for Alzheimer Disease: An Assay Comparison StudyEline A J Willemse, Ann De Vos, Elizabeth M Herries, et al.
Pageof 49

Showing results (351-360 of 489) with videos related to

Sort By:
Pageof 49
Alzheimer'S Research & Therapy|September 27, 2018
Non-beta-amyloid/tau cerebrospinal fluid markers inform staging and progression in Alzheimer's diseaseUmesh Gangishetti, J Christina Howell, Richard J Perrin, et al.
Annals of Neurology|December 24, 2005
Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humansAnne M Fagan, Mark A Mintun, Robert H Mach, et al.
American Journal of Hospital Pharmacy|December 1, 1976
Computerized consultation system for selection of antimicrobial therapyS M Wraith, J S Aikins, B G Buchanan, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 26, 2018
The impact of preanalytical variables on measuring cerebrospinal fluid biomarkers for Alzheimer's disease diagnosis: A reviewOskar Hansson, Alvydas Mikulskis, Anne M Fagan, et al.
IBRO Neuroscience Reports|April 12, 2021
Intracisternal administration of tanshinone IIA-loaded nanoparticles leads to reduced tissue injury and functional deficits in a porcine model of ischemic strokeElizabeth S Waters, Erin E Kaiser, Xueyuan Yang, et al.
Sleep|March 18, 2022
Adverse driving behaviors are associated with sleep apnea severity and age in cognitively normal older adults at risk for Alzheimer's diseaseJason M Doherty, Catherine M Roe, Samantha A Murphy, et al.
Neuroimage. Clinical|March 23, 2019
Quantification of white matter cellularity and damage in preclinical and early symptomatic Alzheimer's diseaseQing Wang, Yong Wang, Jingxia Liu, et al.
Frontiers in Neurology|February 8, 2021
Magnetic Resonance Imaging and Gait Analysis Indicate Similar Outcomes Between Yucatan and Landrace Porcine Ischemic Stroke ModelsSydney E Sneed, Kelly M Scheulin, Erin E Kaiser, et al.
Brain and Behavior|February 28, 2018
Neurodegenerative disease biomarkers Aβ<sub>1-40</sub>, Aβ<sub>1-42</sub>, tau, and p-tau<sub>181</sub> in the vervet monkey cerebrospinal fluid: Relation to normal aging, genetic influences, and cerebral amyloid angiopathyJason A Chen, Scott C Fears, Anna J Jasinska, et al.
Clinical Chemistry|March 11, 2018
Neurogranin as Cerebrospinal Fluid Biomarker for Alzheimer Disease: An Assay Comparison StudyEline A J Willemse, Ann De Vos, Elizabeth M Herries, et al.
Pageof 49